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Faecal carriage of ESBL-producing bacteria is a potential risk for transmission and infection.
Little is known about faecal carriage of antibiotic resistance in Tanzania. This study aimed to
investigate the prevalence of faecal carriage of ESBL-producing Enterobacteriaceae and to
identify risk factors for carriage among young children in Tanzania.
Methodology/Principal Findings
From August 2010 to July 2011, children below 2 years of age were recruited in Dar es
Salaam, including healthy community children (n = 250) and children hospitalized due to
diarrhoea (n = 250) or other diseases (n = 103). ChromID ESBL agar and ChromID
CARBA SMART agar were used for screening. Antimicrobial susceptibility testing was
performed by the disk diffusion method. ESBL genotypes were identified by Real-Time
PCR and sequencing.
The overall prevalence of ESBL carriage was 34.3% (207/ 603). The prevalence of ESBL
carriage was significantly higher among hospitalized children (50.4%), compared to commu-
nity children (11.6%; P < 0.001; OR = 7.75; 95% CI: 4.99–12.03). We found high prevalence
of Multidrug-resistance (94%) among Escherichia coli and Klebsiella pneumoniae isolates.
No resistance to carbapenems was detected. For the majority of isolates (94.7%) we
detected a blaCTX-M-15-like gene. In addition, the plasmid mediated AmpC beta-lactamase
CMY-2 was detected for the first time in Tanzania. ESBL prevalence was significantly higher
among HIV positive (89.7%) than HIV negative (16.9%) children (P = 0.001; OR = 9.99;
95% CI: 2.52–39.57). Use of antibiotics during the past 14 days and age below 1 year was
also associated with ESBL carriage.
Conclusions/Significance
We report a high rate of faecal carriage of ESBL-producing Enterobacteriaceae among chil-
dren below 2 years of age in Tanzania, particularly those with HIV-infection. Resistance to a
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majority of the available antimicrobials commonly used for children in Tanzania leaves few
treatment options for infections when caused by these bacteria.
Introduction
Antimicrobial resistance is a serious problem worldwide. Infections caused by resistant organ-
isms pose an important challenge for treatment of both common and life-threatening infec-
tions. The World Health Organization (WHO) has declared infections caused by multidrug
resistant bacteria as an emerging global health problem of major public health concern [1].
Beta-lactam antibiotics include penicillins, cephalosporins and carbapenems, and constitute
the most important group of agents for combating bacterial infections. Extended Spectrum
Beta-Lactamases (ESBLs) are enzymes capable of hydrolysing many beta-lactam antibiotics
and thereby protect ESBL-producing bacteria from the action of these drugs. ESBL-producing
bacteria are frequently associated with co-resistance to non-beta-lactam antimicrobial agents
and resistance to several different antibiotics at the same time (Multidrug-resistance (MDR)),
which may critically complicate the treatment of severe bacterial infections. High prevalence
of ESBL-producing bacteria has been reported worldwide [1–3]. While there are a number of
publications on ESBL-producing bacteria causing clinical infections [4–7], relatively few stud-
ies from the African continent report on carriage of ESBL-producing organisms [8–11].
While a better understanding of the impact on faecal carriage of ESBL-producing bacteria
on subsequent development of infection is needed, carriage is a potential risk for transmission
and infection [12–14], and of particularly concern in healthcare settings, especially in develop-
ing countries where infection control is often inadequate. Little is known about faecal carriage
of ESBLs and antibiotic resistance in Tanzania, with only two studies which have been con-
ducted in the northern part of the country [15, 16]. This study was conducted in the largest
city of Tanzania, Dar es Salaam, with a population of about five million. We aimed to investi-
gate the prevalence of faecal carriage of ESBL-producing Enterobacteriaceae and to identify
risk factors for carriage among young children in Dar es Salaam, Tanzania.
Materials and Methods
Ethics statement
The study was approved by the Muhimbili University of Health and Allied Sciences Institu-
tional Review Board in Dar es Salaam, Tanzania, by the Regional Committee for Medical and
Health Research Ethics (REK) in Norway, and by the respective hospital authorities at the
three study hospitals. Written informed consent was obtained from the parents or guardian on
behalf of all the children enrolled in the study.
Study population
The present work was part of a larger study assessing causes of diarrhoea among children. The
study population and data collection have previously been described [17]. Briefly, this prospec-
tive study was performed between August 2010 and July 2011, in Dar es Salaam, the largest
city in Tanzania with a population of more than four million. Children below 2 years of age
were included and categorized into three different study groups; healthy community children
attending child health clinics for immunization and growth monitoring with no history of
diarrhoea for one month prior to the study enrollment (n = 250), children hospitalized due to
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diarrhoea (n = 250), and children admitted due to diseases other than diarrhoea, also with no
history of diarrhoea during the last month (n = 103). The study hospitals were the three major
hospitals in Dar es Salaam; Muhimbili National Hospital and Amana and Temeke Municipal
district hospitals. A standardized questionnaire and patient files were used for collection of
demographic and clinical information. Weight for age (WAZ), length for age (LAZ) and
weight for length (WLZ) Z-scores were calculated using EPI Info (USD, Inc., Stone Mountain,
GA). Children were categorized to have normal nutritional status, mild or severe malnutrition
using Z-scores according to WHO criteria [18]. Use of antibiotics during the last 14 days prior
to study enrollment was recorded.
Sample material
One stool specimen from each community and hospitalized child was collected on inclusion
in the study and cultured on MacConkey agar within six hours. For hospitalized children the
sample was collected within the first 24 hours upon admission. A sweep of bacterial colonies
from MacConkey agar was stored at—80˚C. A portion of each specimen was shipped on dry-
ice to Bergen, Norway, for further analysis, including ESBL screening and genotyping.
Phenotypic screening for ESBL-producing Enterobacteriaceae
Frozen bacterial samples were sub-cultured on non-selective media and over-night cultures
were re-suspended in 0.85% saline. 2–3 x 105 CFU, resulting in abundant growth still enabling
identification of single colonies with different morphology, was used as inoculum for screen-
ing. ChromID ESBL agar (for screening for ESBL-producing Enterobacteriaceae, both the clas-
sical ESBLs inhibited by clavulanic acid and the AmpC enzymes) and ChromID CARBA
SMART (for combined screening for carbapenemase producing Enterobacteriaceae and the
specific screening for OXA-48 producing Enterobacteriaceae), were used according to the
manufacturer’s instructions (BioMérieux, Marcy l’Etoile, France). The following quality con-
trol strains were used: Klebsiella pneumoniae ATCC 700603, Escherichia coli ATCC 25922, and
molecularly characterized strains harboring different combinations of beta-lactamase genes
provided by the Norwegian National Advisory Unit on Detection of Antimicrobial Resistance
including E. coli harboring blaOXA-48, blaCTX-M-15 and blaCTX-M-14, E. coli harboring blaNDM-1,
blaCMY-16 variant, blaCTX-M-15, blaOXA-1, blaOXA-10 and blaTEM-1, K. pneumoniae harboring
blaOXA-48 and blaSHV-11 and K. pneumoniae harboring blaKPC-2, blaSHV-11 and blaTEM-1.
Identification and susceptibility testing of the bacterial isolates
Isolates were identified with MALDI-TOF MS using the Microflex LT instrument and MALDI
Biotyper 3.1 software (Bruker Daltonics, Bremen, Germany). Only one isolate of each species
was included for each patient. Antimicrobial susceptibility testing was performed by the disk
diffusion method and classified as susceptible or resistant according to the European Commit-
tee on Antimicrobial Susceptibility Testing (EUCAST) guidelines for aztreonam, cefepime,
cefoxitin, chloramphenicol, ciprofloxacin, gentamicin, meropenem, tigecycline and trimeto-
prim-sulfamethoxazole [19]. When there were no zone diameter breakpoints available for the
disk concentration used (for cefotaxime, ceftazidime, doxycycline and piperacillin-tazobac-
tam) or no zone diameter breakpoints yet available for an agent (fosfomycin), then the Clinical
and Laboratory Standards Institute’s (CLSI) guidelines was used [20]. Isolates showing inter-
mediate resistance were categorized as resistant. Confirmation of ESBL phenotype was per-
formed using the BBL Sensi-Disc ESBL Confirmatory Test Disks (Becton Dickinson, Sparks,
MD, USA). Quality control strains were included.
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Real-Time PCR and sequencing for detection and identification of ESBL
genotypes
All isolates were examined for the presence of blaCTX-M genes by a Real-Time PCR assay with
forward primer CTXM-F 5’-ATGTGCAGYACCAGTAARGT-3’, and reverse primers
CTXM-R1 5’-TGGGTGAAGTAAGTGACCAGA-3’ and CTXM-R2 5’-TGGGTAAARTAGGTC
ACCAGA-3’ (TIB Molbiol, Berlin, Germany), which target a 595 bp internal region present in
all the five different CTX-M phylogenetic groups. Genomic DNA was extracted by a rapid
boiling procedure and stored at -70˚C until PCR analysis. The reaction mix included: 1 x
SYBR Premix Ex Taq (Tli RNaseH Plus) (TaKaRa, Otsu, Japan), 0.4 μM each of the primers,
2 μl of sample DNA and water to a total volume of 25 μl. The Real-Time PCR assay was per-
formed using a LightCycler 480 Instrument II (Roche Diagnostics, Mannheim, Germany),
with cycling conditions as follows: 95˚C for 30 sec, followed by 35 cycles at 95˚C for 10 sec,
60˚C for 10 sec and 72˚C for 30 s each, and then cooled to 40˚C for 30 s. All samples were run
on LightCycler 480 Multiwell Plate 96, white (Roche), and sealed with LightCycler 480 Sealing
Foil (Roche). Each run included duplicate of a positive control and multiple no-template con-
trols. Amplicons were sequenced using the reverse primers and BigDye Terminator v1.1 Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and an ABI PRISM 3730 DNA
Analyzer (Applied Biosystems). Sequences were analyzed using the RipSeq software (Patho-
genomix Inc., CA, USA).
Isolates with a negative CTX-M PCR result were examined for the presence of blaSHV
genes by a previous published method detecting SHV5/12-like ESBLs [21]. All isolates resis-
tant to cefoxitin were examined for the presence of plasmid mediated AmpC beta-lactamase
(blaCMY-2) as previously described [21].
Statistical analysis
Statistical analysis was performed using SPSS Statistics version 23 (SPSS Inc., Chicago, IL,
USA). Chi-square test was used to compare proportions. Univariate and multivariate analysis
were performed using logistic regression. Multivariate analysis of characteristic features for
faecal carriage of ESBL-producing Enterobacteriaceae included the following nine variables;
sex, age, place of residence, parent level of education, underweight, stunting, wasting, HIV sta-
tus and use of antibiotics. A P-value < 0.05 was considered statistically significant.
Results
Study population
Of the 603 children enrolled, 242 were females and 361 were males. Of these, 289 were from
Ilala, 179 from Kinondoni and 135 from the Temeke district. Age distribution was 372 chil-
dren equal to or below 12 months, and 231 children above 12 months. HIV testing results
were available for 348 of the children, of whom 29 had a positive test result and 319 had a nega-
tive test result.
Prevalence of screening positive ESBL-producing Enterobacteriaceae
Of all 603 children, 34.3% screened positive for ESBL by the ChromID ESBL agar. None of the
samples screened positive for carbapenemases using the ChromID CARBA SMART media. The
prevalence of ESBL carriage for the different study groups is shown in Table 1. ESBL prevalence
was significantly higher among both children hospitalized due to diarrhoea and among children
hospitalized due to diseases other than diarrhoea, than among community children. The differ-
ence between the two groups with hospitalized children was not statistically significant.
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Identification and susceptibility testing of the bacterial isolates
Screening identified 284 bacterial isolates from 207 children. Of these, 139 were identified as
K. pneumoniae, 129 were E. coli, 11 were Enterobacter cloacae complex, 2 were Klebsiella oxy-
toca, 2 were Citrobacter spp. and 1 was Proteus mirabilis. Carriage of two different bacteria spp.
was detected in 75 (36.2%) of the participants with a positive screening. Only one sample con-
tained more than two different bacteria spp. The prevalence of more than one ESBL-producing
isolate was highest among the screening positive children hospitalized due to diarrhoea (56;
47.5%), followed by the screening positive children hospitalized due to other diseases (16;
26.7%) and the screening positive community children (4; 13.8%).
Resistance to different antimicrobial agents is shown in Table 2. The ESBL screening posi-
tive isolates showed high rates of resistance to antimicrobials commonly used in Tanzania. All
isolates were susceptible to meropenem. MDR, defined as resistance to three or more catego-
ries of antimicrobial agents other than cephalosporins and aztreonam, was highly prevalent,
with around 94% of E. coli and K. pneumoniae and more than 80% of E. cloacae complex iso-
lates being MDR. Co-resistance to ciprofloxacin, gentamicin and trimethoprim-sulfamethoxa-
zole was detected in about half of the E. coli and E. cloacae complex isolates and in about 14%
of the K. pneumoniae isolates.
ESBL genotypes
A CTX-M genotype was detected in 94.7% (269/ 284) of the ESBL screening positive bacteria
from 198 children. The distribution of a CTX-M-15 like genotype among the different bacteria
spp. was as follows: 121 E. coli, 133 K. pneumoniae, 2 K. oxytoca, 10 E. cloacae complex and 1
Citrobacter spp. A CTX-M-14 like genotype was found in 2 E. coli. An ESBL type blaSHV gene,
SHV-5/12 like, was detected in 4 of the CTX-M negative isolates. Three of the 33 isolates resis-
tant to cefoxitin were positive for CMY-2. They were all E. coli and two of them were also har-
boring CTX-M-15 like genes.
Concordance between ESBL screening, genotypes and phenotypes
Of all the 284 screening positive isolates, 9 of them were negative using the ESBL confirmatory
test disks. Of these, 3 isolates were CMY-2 positive, 3 isolates were resistant to cephalosporins,
and the last 3 isolates were sensitive to cephalosporins. Only for five of the ESBL screening pos-
itive patients an ESBL genotype was not found.
Characteristics of faecal carriage of ESBL-producing Enterobacteriaceae
The characteristics of faecal carriage of ESBL-producing isolates are shown in Table 3. HIV
status was not known for all children, therefore multivariate analysis was first performed by
including all children but without HIV status as a variable, and then by only including the 348
children with known HIV status. Multivariate analysis showed that age equal to or below 12
months was significantly associated with ESBL carriage (P = 0.012; OR = 1.82; 95% CI: 1.14–
2.91). To further assess the impact of age, children were categorized into five age groups. The
Table 1. Prevalence of ESBL screening positive children in the different study groups.
Study group ESBL screening positive (%) P; OR (95% CI)
Community children 29 (11.6) 1
Children hospitalized due to diarrhoea 118 (47.2) < 0.001; 6.81 (4.30–10.79)
Children hospitalized due to other diseases 60 (58.3) < 0.001; 10.63 (6.13–18.44)
doi:10.1371/journal.pone.0168024.t001
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prevalence of ESBL carriage in these five age groups is illustrated in Fig 1. With a prevalence of
68.4% (39/57) among children aged 0–3 months (P < 0.001; OR = 8.83; 95% CI: 3.87–20.15, of
56.3% (36/64) among children aged 4–6 months (P < 0.001; OR = 5.24: 95% CI: 2.40–11.16)
and 34.3% (86/251) among children aged 7–12 months (P = 0.025; OR = 2.13; 95% CI: 1.10–
4.11), infants had a significantly higher risk of carrying ESBL than children above 12 months.
Living in the Kinondoni district was significantly associated with ESBL carriage in both
univariate and multivariate analysis (P = 0.020; OR = 1.58; 95% CI: 1.07–2.34 (univariate) and
P = 0.001; OR = 2.62; 95% CI: 1.49–4.60 (multivariate)). Further, in both univariate and multi-
variate analysis, ESBL carriage was significantly more prevalent in HIV positive children than
in HIV negative children (P< 0.001; OR = 42.53; 95% CI: 12.43–145.57 (univariate) and
P = 0.001; OR = 9.99; 95% CI: 2.52–39.57 (multivariate)). Stunting was significantly associated
with ESBL carriage in the univariate analysis including all children (), but was not a significant
risk factor in the multivariate analysis.
Children who had used antibiotics during the last 14 days prior to study enrollment were
more likely to carry ESBL-producing strains that those who had not taken antibiotics
(P = 0.022; OR = 1.61; 95% CI: 1.07–2.41).
In univariate analysis, children of parents with a higher level of education were significantly
more likely to be ESBL carriers than those with lower levels of education (P = 0.017; OR =
6.90; 95% CI: 1.42–33.50), but this association was not significant in multivariate analysis.
The prevalence of ESBL carriage upon admission at the different study hospitals was also
assessed. The prevalence of ESBL carriage upon admission was significantly higher among
children admitted to Muhimbili National Hospital (76%, 98/129) than among those admitted
Table 2. Susceptibility to antimicrobial agents for the ESBL screening positive bacteria.
Prevalence of resistant isolates (%)
E. coli K. pneumoniae K. oxytoca E. cloacae complex P. mirabilis Citrobacter spp.
Antimicrobial agent (N = 129) (N = 139) (N = 2) (N = 11) (N = 1) (N = 2)
Aztreonam1 97.7 99.3 100 100 0 50
Cefepime1 97.7 98.6 100 90.9 0 50
Cefotaxime2 99.2 100 100 100 0 50
Cefoxitin1 15.5 1.4 0 100 0 0
Ceftazidime2 96.9 97.8 100 100 0 50
Chloramphenicol1 41.9 71.2 100 81.8 100 0
Ciprofloxacin1 62.8 17.3 100 63.6 100 0
Doxycycline2 80.6 25.2 0 54.5 100 0
Fosfomycin2,3 0 1.4 0 0 0 0
Gentamicin1 77.5 92.8 100 90.9 0 50
Meropenem1 0 0 0 0 0 0
Piperacillin-Tazobactam2 45.7 84.2 100 36.4 0 50
Tigecycline1,3 0 7.2 0 0 0 0
Trimethoprim-Sulfamethoxazole1 98.4 99.3 100 81.8 100 0
Multidrug-resistance I4 93.8 94.2 100 81.8 100 0
Multidrug-resistance II5 50.4 14.4 100 63.6 0 0
1EUCAST guidelines applied.
2CLSI guidelines applied.
3Zone diameter breakpoints validated for E. coli only.
4Multidrug-resistance I defined as resistance to three or more of the antibacterial agents in the table.
5Multidrug-resistance II defined as resistance to ciprofloxacin, gentamicin and trimethoprim-sulfamethoxazole.
doi:10.1371/journal.pone.0168024.t002
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to Amana District Hospital (39.2%, 65/166) or Temeke District Hospital (25.9%, 15/58, P <
0.001; OR = 9.06; 95% CI: 4.44–18.59) (Table 4).
Discussion
This is the first study from Tanzania reporting on ESBL carriage among very young children,
including both healthy and sick children from the community. Faecal carriage of ESBL
Table 3. Characteristics of faecal carriage of ESBL screening positive bacteria among children in Dar es Salaam, Tanzania.
Characteristics ESBL screening positive children
NChildren n (%) Univariate Multivariate2 Multivariate3
P; OR (95% CI) P; OR (95% CI) P; OR (95% CI)
Sex
Male 361 134 (37.1) 0.078;1.37 (0.97–1.94) 0.24; 1.27 (0.85–1.91) 0.58; 1.20 (0.63–2.31)
Female 242 73 (30.2) 1 1 1
Age
 12 months 372 161 (43.3) <0.001; 3.07 (2.09–4.50) 0.012; 1.82 (1.14–2.91) 0.55; 1.25 (0.61–2.54)
> 12 months 231 46 (19.9) 1 1 1
Place of residence (district)
Ilala 289 89 (30.8) 1 1 1
Temeke 135 44 (32.6) 0.710; 1.09 (0.70–1.68) 0.91; 1.03 (0.62–1.70) 0.40; 1.55 (0.56–4.29)
Kinondoni 179 74 (41.3) 0.020; 1.58 (1.07–2.34) 0.001; 2.62 (1.49–4.60) 0.014; 3.34 (1.28–8.72)
Parent level of education
Higher level 9 7 (77.8) 0.017; 6.90 (1.42–33.50) 0.34; 2.19 (0.43–11.16) P = 1.0
Secondary, Primary and below 594 200 (33.7) 1 1 1
Children groups
Community 250 29 (11.6) 1 1 1
Diarrhoea 250 118 (47.2) <0.001; 6.81 (4.30–10.79) <0.001; 5.32 (3.13–9.04) <0.001; 5.98 (2.28–17.72)
Other diseases 103 60 (58.3) <0.001; 10.63 (6.13–18.44) <0.001; 10.08 (5.39–18.83) <0.001; 34.32 (2.78–424.14)
Nutritional status
WAZ
Normal weight 329 104 (31.6) 1 1 1
Underweight 274 103 (37.6) 0.12; 1.30 (0.93–1.83) 0.15; 1.42 (0.89–2.29) 0.99; 1.00 (0.48–2.09)
LAZ
Normal 257 68 (26.5) 1 1 1
Stunted 346 139 (40.2) <0.001; 1.87 (1.31–2.65) 0.12; 1.45 (0.91–2.31) 0.20; 1.65 (0.76–3.56)
WLZ
Normal 454 163 (35.9) 1 1 1
Wasting 149 44 (29.5) 0.16; 0.75 (0.50–1.12) 0.48; 0.83 (0.48–1.41) 0.15; 0.50 (0.20–1.29)
HIV
Positive 29 26 (89.7) <0.001; 42.53 (12.43–145.57) Not applicable 0.001; 9.99 (2.52–39.57)
Negative 319 55 (16.9) 1 1
Use of antibiotics1
No use 378 100 (26.5) 1 1 1
Used 225 107 (47.6) <0.001; 2.52 (1.78–3.57) 0.022; 1.61 (1.07–2.41) 0.37; 1.38 (0.68–2.80)
N: Total number of samples tested; n: number of positive samples; WAZ: Weight-for-age-Z-score; LAZ: Length-for-age-Z-score; WLZ: Weight-for-length-Z-
score
1Use of antibiotics during the last 14 days prior to inclusion, or on inclusion.
2 and 3 Multivariate analysis for all children (n = 603) and only children with known HIV status (n = 348), respectively.
doi:10.1371/journal.pone.0168024.t003
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producing Enterobacteriaceae has been documented in both children and in adults [8, 10, 15,
22–24]. A global prevalence of 14% ESBL carriage among healthy individuals has been
reported [23].
Data on ESBL carriage among community children on the sub-Saharan continent are lim-
ited [9, 11, 15, 25], and numbers of children included in previous studies are low. There is only
one publication on ESBL carriage in the community in Tanzania [15]. The overall prevalence
of ESBL carriage is comparable to the prevalence of about 30% found among children admit-
ted at hospitals in Guinea-Bissau, Gabon and Niger [8, 9, 26]. The ESBL carriage differed sig-
nificantly between healthy and hospitalized children. Carriage rate among healthy community
children in our study is comparable to the prevalence of 16.5% found in community settings in
Mwanza in northern Tanzania, including both children and adults [15]. However, it is twice
the prevalence found among healthy children in France [27], but still half the prevalence found
among children in Laos and Lebanon [22, 28] and much lower than the prevalence of 59%
found among children in Bangui [11]. We observed a very high carriage rate among hospital-
ized children. This is higher than in studies from Guinea-Bissau, Gabon, Madagascar and
Niger [8, 9, 25, 26]. At the hospital level, alarmingly 76% of the children are ESBL carriers
when admitted at the Muhimbili National Hospital. Data on previous hospitalization was not
available, but as this is a national referral hospital, it is likely that a substantial proportion of
these children have a history of previous hospitalization, which might have contributed to
Fig 1. Prevalence of ESBL carriage in different age groups. The graph shows the prevalence (%) of ESBL
carriage among the study participants when categorized into five different age groups.
doi:10.1371/journal.pone.0168024.g001
Table 4. Prevalence of ESBL carriage among children admitted at each of the study hospitals.
Hospital ESBL screening positive (%) P; OR (95% CI)
Muhimbili National Hospital 98/129 (76) < 0.001; 9.06 (4.44–18.59)
Amana District Hospital 65/166 (39.2) 0.07; 1.85 (0.95–3.59)
Temeke District Hospital 15/58 (25.9) 1
doi:10.1371/journal.pone.0168024.t004
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colonization. This is supported by studies showing acquisition rates during hospitalization of
47.5% and 94%, respectively [25, 26].
We found carriage of more than one bacterial species more common among children admit-
ted due to diarrhoea. Carriage of more than one bacterial species might increase the risk of
transfer of genetic elements carrying resistance genes. In this study we did not aim for extensive
molecular characterization, however the high prevalence of the CTX-M-15 like genotype further
confirms the CTX-Ms as the dominant enzyme among carriers both in Tanzania and world-
wide [15, 23]. The plasmid mediated AmpC gene blaCMY-2 was detected in three E. coli isolates,
and this is the first report of CMY-2 in Tanzania. Only blaCTX-M negative isolates were assessed
for presence of blaSHV, hence the prevalence of SHV-type ESBLs might be underestimated.
With an ESBL genotype identified for 97.6% of the patients, the screening media showed high
specificity, which possibly would have been higher if other ESBL genotypes were search for.
The ESBL positive isolates showed high rates of resistance to antimicrobials available and
commonly used in Tanzania, and very high levels of MDR. Empirical treatment according to
guidelines in this setting has been associated with high case-fatality rates [29]. Resistance to the
majority of drugs most commonly used for infections in children leaves very few choices for
treatment. WHO recommend continued co-trimoxazole prophylaxis until adulthood for all
HIV positive children in settings like Tanzania. Considering a resistance rate for co-trimoxa-
zole close to 100%, together with a high level of co-resistance to other commonly used antimi-
crobials, adhering to these guidelines might contribute to increased selection for resistance
against other available antimicrobial agents. Carbapenemases were not detected, but the study
was conducted around the time at which carbapenems were introduced in Tanzania, hence
new studies on the prevalence of these enzymes are needed.
We identified younger age, HIV infection and use of antibiotics as independent factors
associated with ESBL carriage. Notably, being a resident of the Kinondoni district, which set-
tles people with a higher level of income, was also significantly associated with ESBL carriage.
In a setting were economical resources are limited, higher income increases affordability to
antimicrobial treatment. Living in a highest income family was the only risk factor for carriage
in the study from Bangui [11]. Several studies have reported on age as a risk factor for carriage,
but the impact of age on faecal ESBL carriage varies with the age range of the study population
and the study setting [9, 15, 23, 30]. Although our study included young children within a lim-
ited age range, younger age was significantly associated with ESBL carriage. Both the very
youngest children, aged 0–3 months, and those aged 4–6 months, were nine and five times
more likely to be colonized with ESBL positive bacteria than the oldest children, respectively.
This may reflect health-care associated transmission or resistant strains being transmitted
from mothers to their babies, possibly during delivery. Interestingly, Nelson et al. did not find
any phenotypic similarity between ESBL strains from women and their newborns, and half of
the newborns acquired ESBL producing bacteria already at their first day of life [16]. In con-
trast, Denkel et al. did identify ESBL colonization of the mother as an independent risk factor
for colonization of neonates [31]. However, results should be interpreted with caution, as risk
factors might not be the same in a high prevalence setting in the developing world as in a low
prevalence setting in the developed world.
HIV positive children were ten times more likely to be ESBL carriers than those who were
HIV negative. HIV status has not been well documented as a risk factor for ESBL carriage.
HIV positive children are more prone to infections and hence more likely to be hospitalized
and consume antimicrobials than HIV negative children. HIV-infection has been associated
with resistant bacteria [32–34]. Considering the very strong association between ESBL carriage
and HIV-infection, together with a positive HIV status of 8% among these very young chil-
dren, further elucidation is urgent.
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Stunted children were significantly more at risk of ESBL carriage. Malnourished children
with impaired immunity are more vulnerable to infections, and are hence more likely to be
treated with antibiotics. Previous use of antibiotics as far back as 12 months before sampling
has been described as a risk factor for carriage [22, 23]. Even though only very recent data on
use of antimicrobials were available, use of antimicrobials the last 2 weeks prior to study enroll-
ment was significantly associated with ESBL carriage. Children that used antibiotics had nearly
a two-fold increased risk for carriage compared to those that did not use antibiotics. If a longer
history of use was available, this link could possibly be even stronger.
Immediate action is needed to prevent resistant bacteria spreading in the community and
healthcare facilities. In developing countries, high level of antibiotic consumption is related to
high prevalence of infections. To reduce the use of antibiotics, stewardship and guidance on
appropriate use is extremely important. Prevalence of infections can be reduced by better
access to and coverage of vaccination, better hygienic precautions, improving sanitation, and
improvement of nutritional status. Retroviral treatment of HIV positive pregnant women to
reduce mother-to-child transmission should be increased.
This study highlights a worryingly high faecal carriage of ESBL producing—and MDR bac-
teria among children below 2 years of age. It is the first study on ESBL carriage among young
community children in Tanzania, including both healthy children and children with illness.
Few studies exist from other sub-Saharan countries. Treatment options for infections caused
by these bacteria are limited. The link between carriage and infection needs further elucida-
tion. Carriage contributes to a considerable circulating pool of resistance genes and strict anti-
biotic stewardship and measures to prevent infections need immediate attention.
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